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Emma L. Dempster, Chloe C.Y. Wong, Kathryn J. Lester, Joe Burrage, Alice M. Gregory,
Jonathan Mill, and Thalia C. EleyBackground: Adolescent depression is a common neuropsychiatric disorder that often continues into adulthood and is associated with
a wide range of poor outcomes including suicide. Although numerous studies have looked at genetic markers associated with
depression, the role of epigenetic variation remains relatively unexplored.
Methods: Monozygotic (MZ) twins were selected from an adolescent twin study designed to investigate the interplay of genetic and
environmental factors in the development of emotional and behavioral difﬁculties. There were 18 pairs of MZ twins identiﬁed in which
one member scored consistently higher (group mean within the clinically signiﬁcant range) on self-rated depression than the other. We
assessed genome-wide patterns of DNA methylation in twin buccal cell DNA using the Inﬁnium HumanMethylation450 BeadChip from
Illumina. Quality control and data preprocessing was undertaken using the wateRmelon package. Differentially methylated probes
(DMPs) were identiﬁed using an analysis strategy taking into account both the signiﬁcance and the magnitude of DNA methylation
differences. The top differentially methylated DMP was successfully validated by bisulﬁte-pyrosequencing, and identiﬁed DMPs were
tested in postmortem brain samples obtained from patients with major depressive disorder (n ¼ 14) and matched control subjects (n ¼ 15).
Results: Two reproducible depression-associated DMPs were identiﬁed, including the top-ranked DMP that was located within STK32C,
which encodes a serine/threonine kinase, of unknown function.
Conclusions: Our data indicate that DNA methylation differences are apparent in MZ twins discordant for adolescent depression and
that some of the disease-associated variation observed in buccal cell DNA is mirrored in adult brain tissue obtained from individuals with
clinical depression.Key Words: Adolescent depression, depression, DNA methylation,
epigenetic, genomics, monozygotic twins
Depression is a common chronic psychiatric disordercharacterized by episodes of severe low mood. Depressionranks second in global disease burden (1), but despite
extensive research, its etiology is not well understood. The
heritability of depression is estimated to be 31%–42% (2),
although genome-wide association studies have been unable to
identify reproducible association signals (3). Although some of
this lack of replication in genetic studies can be explained by the
heterogeneous nature of depression, increased understanding
about the functional complexity of the genome has led to
growing recognition about the likely role of non–sequence-based
variation in disease etiology (4,5).
Despite the apparently high heritability of depression, there is
considerable discordance within monozygotic (MZ) twin pairs (6),
implicating a role for nongenetic, presumably environmental,
factors. One mechanism by which the environment can have an
impact on individual development is via epigenetic changes to
gene expression. Epigenetic mechanisms mediate developmentalAuthors JM and TCE contributed equally to this work.
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tion, principally through alterations in DNA methylation and
chromatin structure (7). Epigenetic processes have been shown
to underlie much of the plasticity in the mature central nervous
system, playing a key role in learning and memory and enabling
the brain to respond to environmental stimuli (8). Accumulating
evidence from animal models indicates that many environmental
stressors in early life associated with an increased risk of
depression can precipitate epigenetic changes in the brain (9),
although most research has focused on a single gene or func-
tional pathway (10–13). Emerging evidence implicates a role for
epigenetic modiﬁcations across the genome in several human
neuropsychiatric disorders, including depression (4). Although
few empirical studies have systematically examined the role of
altered epigenetic processes in depression, more recent analyses
provide evidence for altered DNA methylation and histone
modiﬁcations in the disorder (14–17).
Adolescence is a unique period characterized by both physical
and emotional development and exposure to novel environ-
mental stressors (18). It is a period of active brain maturation,
characterized by processes such as synaptic pruning (19), and is
the developmental stage when the signs of many psychiatric
disorders ﬁrst manifest (20). The prevalence of depression
dramatically increases during adolescence, particularly in girls
(21). Once established, adolescent depression commonly contin-
ues into adulthood and is associated with a wide range of poor
outcomes including suicide (22,23).
To identify epigenetic variation associated with adolescent
depression, we examined genome-wide patterns of DNA meth-
ylation in buccal cell–derived DNA from MZ twin pairs discordant
for adolescent depression symptoms assessed at multiple time
points. The use of disease-discordant MZ twins is a power-
ful strategy in epigenetic epidemiology because identical twins
are matched for genotype, age, sex, maternal environment,BIOL PSYCHIATRY 2014;76:977–983
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mental factors (24,25). DNA methylation differences have been
associated with MZ twin discordance for several complex pheno-
typic traits, including psychosis (26), autism (27), and type 1
diabetes (28). In the context of depression, the use of adolescent
twins has the advantage that DNA methylation is less likely to be
inﬂuenced by other environmental factors, lifestyle choices, and
medication exposure, which can confound studies in older clinical
cohorts.Methods and Materials
Sample Description
This study was nested within the Genesis 12–19 (G1219) Study,
an adolescent twin and sibling study (N ¼ 1300 pairs) designed to
investigate the development of emotional and behavioral difﬁculties
focusing on the interplay of genes and environment (18). The twins
were recruited via the United Kingdom Ofﬁce of National Statistics,
and four waves of data have been collected to date. At each wave,
participants completed the Short Mood and Feelings Questionnaire
(SMFQ) (29), a self-report measure of depression symptoms. Scores
on this measure range from 0–26 (mean, 7). The mean difference
score within the Genesis 12–19 Study twin/sibling pairs at each
wave ranged from 4.06–5.13 (SD, 3.99–4.80). We designated a
difference of 6 (i.e., approximately 1.5 times the SD of the difference)
as representing sufﬁcient discordancy to be of interest for the
current study and identiﬁed 18 MZ twin pairs (13 female pairs,
5 male pairs, all Caucasian) with consistent discordancy on at least
two measurement occasions. The mean SMFQ score for each of the
twin pair members with depression was 12.38 [1 SD above the
clinical threshold of 8 (29)], and the cotwin group mean was 6.42.
Twins did not differ signiﬁcantly on number or severity of self-
reported life events at any of the assessment time points. Because
this was a population-based sample, DNA was obtained from buccal
cells (mean age, 16.8 years; SD, 2.4), and DNA was isolated using a
standard protocol (30).
Methylomic Proﬁling
DNA was converted with sodium bisulﬁte in duplicate using the
EZ-96 DNA methylation kit (Zymo Research Corporation, Irvine,
California) and proﬁled using the Inﬁnium HumanMethylation450
BeadChip (Illumina, Inc, San Diego, California) as previously
described (30). Each twin pair was processed together on the same
array to negate batch effects. Raw data were preprocessed using
GenomeStudio software (Illumina, Inc). Stringent quality control
checks, quantile normalization, and separate background adjust-
ment of methylated and unmethylated intensities of type I and II
probes were implemented using the wateRmelon package in R
(available from the bioConductor repository www.bioconductor.org)
(30). Only samples with 5% of sites with a detection p value  .05
were included, and probes with 5% of samples with a detection
p value  .05 or a bead count 3 in 5% of samples were removed
from the analysis. The ﬁnal analysis included 439,846 probes, and all
samples passed our stringent quality control ﬁlter. Polymorphic
single nucleotide polymorphism control probes located on the array
were used to conﬁrm that all twin pairs were monozygous. With the
aim of identifying real, biologically relevant within-twin and
between-group DNA methylation differences, we used an analytic
approach that incorporates both the signiﬁcance (i.e., paired t test
statistic) and the magnitude (i.e., absolute Δβ) of any observed
differences to produce a ranked list of differentially methylated
probes (DMPs) (26,27). Brieﬂy, probes were ranked separately bywww.sobp.org/journalpaired t test p value and Δβ, and the ranks were summed (Figure S1
in Supplement 1). An F test was used to examine whether the
variances between affected and unaffected groups for each individ-
ual probe differed. To test the overall mean variance across all
probes between the two groups, the variance was calculated for
each probe in each group separately, and the resulting distributions
were compared using the Wilcoxon signed rank test. Region level
analysis was performed using the Bioconductor package Illumina
Methylation Analyzer (31). Genes were assigned to probes using the
Genomic Regions Enrichment of Annotations Tool (GREAT) package
from the Bejerano Lab at Stanford University (http://bejerano.
stanford.edu/great/public/html) (32) taking into account the func-
tional signiﬁcance of cis-regulatory regions. Pathway and network
analysis was performed using Ingenuity Pathway Analysis (Ingenuity
Systems, Redwood City, California). Enrichment for speciﬁc pathways
and biological functions was determined relative to the proprietary
database, using a right-tailed Fisher’s Exact Test at a signiﬁcance
level of p  .05.
DMP Validation Using Bisulﬁte Pyrosequencing
We performed independent veriﬁcation analyses on the high-
est ranked depression-associated probe (cg07080019, STK32C)
nominated from the genome-wide microarray analysis using
bisulﬁte pyrosequencing. The assay spanned multiple CpG sites,
including the speciﬁc CpG interrogated on the Inﬁnium Human-
Methylation450 BeadChip array. Brieﬂy, 500 ng DNA from each
individual was independently treated with sodium bisulﬁte in
duplicate using the EZ 96-DNA methylation kit as described
earlier. Bisulﬁte–polymerase chain reaction ampliﬁcation was
performed in duplicate, and quantitative DNA methylation anal-
ysis was conducted using the PyroMark Q24 pyrosequencer
(Qiagen, Valencia, California) (Table S1 in Supplement 1).
Replication in Postmortem Brain Tissue
Postmortem cerebellum samples were obtained from the Stanley
Brain Collection at the Stanley Medical Research Institute (Rockville,
Maryland) (33) from individuals with a diagnosis of major depressive
disorder (MDD) (n ¼ 14) and from unaffected individuals with no
diagnosed psychiatric disorder (n ¼ 15) as control samples. Detailed
demographic information for these samples is given in Table S2 in
Supplement 1. DNA was isolated from 70 mg of tissue using a
standard phenol-chloroform extraction protocol, sodium bisulﬁte
treated in duplicate, and proﬁled using the Inﬁnium HumanMethy-
lation450 BeadChip as described earlier. Cases and controls were
randomly assigned and run as a single batch to minimize any
technical confounding. DNA methylation data for speciﬁc probes
nominated from our discordant MZ twin analysis were assessed for
an association with major depression.Results
Site-Speciﬁc DNA Differences Are Widespread in MZ Twins
Discordant for Depression
Using an analysis method designed to identify the largest and
most signiﬁcant differences in DNA methylation at individual CpG
sites, we identiﬁed multiple CpG sites across the genome
exhibiting signiﬁcant depression-associated differential DNA
methylation. The 10 top-ranked DMPs are shown in Table 1 and
Figure 1 (the 100 top-ranked DMPs are listed in Table S3 in
Supplement 1). The top ranked DMP (cg07080019, Δβ ¼ .07,
p ¼ .0001) is located in the eighth intron of STK32C on
chromosome 10q36.3, encoding a serine/threonine kinase of
Table 1. Ten Top-Ranked DMPs in MZ Twins Discordant for Adolescent Depression
Rank Probe Mean Δβ p Value Genomic Coordinate (hg19) Gene (Distance from TSS)
1 cg07080019 .07 .000144 Chr10:134036804 DPYSL4 (36391), STK32C (84672)
2 cg12721804 .06 .001758 Chr8:29194923 KIF13B (74314), DUSP4 (13343)
3 cg24618467 .05 .000822 Chr2:11245514 PQLC3 (50025), KCNF1 (193452)
4 cg02495760 .05 .000950 Chr12:48356074 TMEM106C (1255)
5 cg24644902 .06 .003038 Chr10:77036275 COMTD1 (40506), ZNF503 (125237)
6 cg10651583 .05 .001586 Chr12:57941069 KIF5A (2777), DCTN2 (92)
7 cg04897932 .04 .000225 Chr17:8460923 MYH10 (73112), NDEL1 (121745)
8 cg09090376 .05 .003880 Chr11:33040743 DEPDC7 (3334), CSTF3 (142293)
9 cg26180263 .05 .003454 Chr14:58429389 SLC35F4 (96798), C14orf37 (189457)
10 cg25966908 .05 .001861 Chr7:55516751 LANCL2 (83611), VOPP1 (123448)
Ranked by a combination of both mean absolute difference in methylation level and statistical signiﬁcance.
DMPs, differentially methylated probes; MZ, monozygotic; TSS, transcription start site.















































































































































































Figure 1. Difference in DNA methylation (β value) between twins for the eight top-ranked probes (twin with depression–cotwin without depression).
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Figure 2. Validation and cross-tissue replication of the top-ranked differentially methylated probe (cg07080019) via bisulﬁte pyrosequencing. Inﬁnium
HumanMethylation450 BeadChip array (A) and bisulﬁte-pyrosequencing (B) data for cg07080019 across each discordant twin pair. Methylation levels
estimated by pyrosequencing are slightly lower than the array but conﬁrm depression-associated hypermethylation (p ¼ .02). One twin pair (pair 17) was
removed from analyses because of failed ampliﬁcation. (C) Group comparison of DNA methylation at cg07080019 in the postmortem cerebellum samples
conﬁrms depression-associated hypermethylation (p ¼ .03). MDD, major depressive disorder; metC%, percentage cytosine methylation.
980 BIOL PSYCHIATRY 2014;76:977–983 E.L. Dempster et al.unknown function that is highly expressed in the brain.
Depression-associated hypermethylation at this DMP was success-
fully validated by bisulﬁte pyrosequencing (p ¼ .02) (Figure 2).
DNA methylation at the three additional CpG sites assessed in
our bisulﬁte-pyrosequencing assay was strongly correlated with
cg07080019 (r2  .98) with mean DNA methylation across the
amplicon being signiﬁcantly associated with depression (p ¼ .01).
Many top-ranked DMPs are associated with genes that have
been previously implicated in depression and other related
neuropsychiatric disorders, including DUSP4 (34), NDEL1 (35),
ACP1 (36), SSTR5 (37), NR3C1 (38), and GABRA3 (39). Network
analysis of the 175 genes associated with the 100 top-ranked
probes using Ingenuity Pathway Analysis highlighted signiﬁcant
enrichment of pathways involved in nervous system development
and function, neurologic disease, and psychological disorders
(Tables S4–S6 in Supplement 1). Nervous system development
and function was the top-ranked biological function (p ¼ 6.15E-
05), including numerous genes ranked highly in our probe-
wise analysis (e.g., DPYSL4, NDEL1, MYH10, KIF5A). Region level
analysis using Illumina Methylation Analyzer identiﬁed several
depression-associated differentially methylated regions (Table S2
in Supplement 1). The top-ranked differentially methylated region
was a 300-bp region in the ﬁrst intron of PLCXD3, encompassing
four probes hypermethylated in affected twins (Δβ ¼ .024;
p ¼ .0005) (Figure S2 and Table S7 in Supplement 1). Four genes
highlighted from the Illumina Methylation Analyzer regional
analysis also were featured in the 100 top-ranked individual
probes from the main analysis: STK32C (the overall top ranked
probe), DOK6 (ranked 16), UBE2D3 (ranked 61), and POLR2I
(ranked 72). None of the top-ranked probes showed signiﬁcant
differences between male and female samples.
Several Top-Ranked DMPs Are Also Associated with MDD in
the Cerebellum
Two of the 10 top-ranked DMPs identiﬁed in buccal cell DNA
from our discordant twins were also found to be signiﬁcantlywww.sobp.org/journalassociated with MDD in postmortem cerebellum samples, includ-
ing our top-ranked probe, cg07080019, which was found to be
signiﬁcantly hypermethylated in MDD cerebellum samples com-
pared with matched control samples (average β difference ¼ .02,
p ¼ .03) (Figure 2C). Probe cg09090376, mapping to the ﬁrst
intron of DEPDC7 and ranked eighth in our discordant twin
analysis, also exhibited signiﬁcant differences in the postmortem
brain samples consistent with differences observed in buccal cells
from the discordant MZ twin pairs (average β difference ¼ .03,
p ¼ .03) (Figure 3).
There Is Increased Variability of DNA Methylation in Twins
with Depression
As expected, no differences in overall mean genome-wide DNA
methylation was seen between twins with depression and unaf-
fected twins (p ¼ .84). However, the difference in variance was
signiﬁcant (p  4.58  1010). Of the individual probes where the
variance was signiﬁcantly different (p  .05), 53% of probes showed
a higher variance in the group with depression compared with the
cotwin control group, which is consistent with a previous study on
MZ twins discordant for MDD (14).
Discussion
The present study is the ﬁrst comprehensive analysis of DNA
methylation differences in adolescent MZ twins discordant for
self-reported depression using a genome-wide approach. The
top-ranked DMP (cg07080019) is located in STK32C, with
depression-associated hypermethylation at this locus being suc-
cessfully validated using bisulﬁte pyrosequencing. We also show
that the same CpG site is signiﬁcantly hypermethylated in
postmortem cerebellum samples from subjects with MDD
compared with control subjects without a psychiatric diagnosis.
The function of STK32C is unknown, but it is highly expressed in
the brain (40). The presence of a low-frequency (minor allele
frequency ¼ 3.57%) CT single nucleotide polymorphism
Figure 3. Replication of differentially methylated probe cg09090376 in cerebellum samples. (A) Probe cg09090376 shows consistent depression-
associated hypomethylation across discordant monozygotic twin pairs (p ¼ .004), which is (B) replicated in postmortem cerebellum samples (p ¼ .03).
MDD, major depressive disorder.
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could potentially confound case-control studies, it is not an issue
for the MZ twin study design where both twins have the same
genotype. Because the differentially methylated region in STK32C
is intronic, it is uncertain whether a DNA methylation change in
this region could alter gene expression or gene splicing. However,
the interrogation of publicly available Encyclopedia of DNA
Elements data (41) shows that this region is situated in a DNAase
I hypersensitivity cluster and contains several transcription factor–
binding sites suggesting that it resides in a transcriptionally active
region of the genome, which could be functionally inﬂuenced by
alterations in DNA methylation.
Several of the other top-ranked DMPs are located in the vicinity
of genes that have previously been implicated in psychiatric
disorders. For example, cg12721804, which is hypermethylated in
affected twins (Δβ ¼ .06, p ¼ .001), is located in the last exon of
DUSP4 (also known as mitogen-activated protein kinase phospha-
tase 2), which has been shown to be unregulated in the brains of
individuals with depression who committed suicide (34). Similarly,
cg04897932, which is hypomethylated in affected twins (Δβ ¼
.04, p ¼ .0002), is located upstream of NDEL1, which forms a
complex with DISC1, an established risk gene for several psychiatric
conditions including major depression (35). Finally, cg24565620,
which was hypomethylated in affected twins (Δβ ¼ .05, p ¼ .004)
is located upstream of ACP1 (acid phosphatase 1), a tyrosine
phosphatase that inﬂuences Wnt signaling, that has been impli-
cated in suicide in genome-wide association studies and expression
analyses (36). Several other genes of note were present in the 100
top-ranked probes, including SSTR5 (37), NR3C1 (38), and GABRA3
(39). NR3C1 is of particular interest given that epigenetic variation
in this region has been associated with early-life stress in both
humans and rodents (42).
A global approach looking across all probes on the array
revealed no signiﬁcant difference between twins with depression
and their unaffected cotwins. However, the variance across
β values in the twins with depression is signiﬁcantly larger thanin the cotwins, consistent with the ﬁndings of a study that looked
at DNA methylation in 12 adult MZ twin pairs discordant for MDD
(14). These data suggest that DNA methylation is more variable in
individuals with depression, potentially indicating that the meth-
ylome of the group with depression is generally more reactive to
external stimuli or stochastic processes. In our study, we found no
signiﬁcant differences in the number of stressful life events
reported by twins with depression and unaffected cotwins.
There is little overlap in the genes associated with our top-
ranked DMPs and the genes identiﬁed in other epigenetic studies
of depression (14,16,17), although direct comparisons are difﬁcult
because of differences in study design, technology platforms,
phenotypic analysis, tissue, and sample size. However, it is
notable that Ingenuity Pathway Analysis network analysis high-
lighted an enrichment of genes involved in nervous system
development and function among our depression-associated
DMPs, which is consistent with previous reports (16,17).
Despite the power of the discordant MZ twin approach for
epigenetic epidemiology, there are several limitations to this study.
First, because of the relatively small sample size and effect sizes
detected, no probe reached Bonferroni-corrected levels of signiﬁ-
cance. However, DNA methylation studies in other psychiatric
phenotypes (and complex disorders in general) report similarly
small absolute differences (26–28), and, given the known non-
independence of DNA methylation across the probes represented
on the array (43), it is likely that conventional methods of global
statistical signiﬁcance are not relevant to these analyses. Instead,
we took steps to validate and replicate our results. Our analytic
approach was to rank DMPs by both statistical signiﬁcance and
absolute difference, and we were able to validate our top-ranked
DMP using bisulﬁte pyrosequencing and to replicate the associa-
tion in brain tissue. A second caveat is that the genome-wide data
generated in this study are from peripheral buccal cell DNA and
not the target organ of depression, the brain. However, in the
absence of availability of brain tissue from MZ twins discordant for
depression, buccal swabs were selected as the most suitablewww.sobp.org/journal
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cells as brain tissue (ectoderm) and have less cellular heterogeneity
compared with blood (44). Although there are well-documented
tissue-speciﬁc differences in DNA methylation (45), a study sug-
gests that some disease epimutations may be detectable across
multiple tissues (46). A related concern is that we had access only
to cerebellum tissue, which may not be the optimal brain region to
study in the context of depression. A third limitation of this study is
that clinical diagnoses of depression were not used. Instead, we
selected MZ pairs in which one twin scored 1.5 SDs higher on
self-reported depressive ratings (SMFQ) than his or her cotwin on
at least two occasions. A cutoff of 8 on this measure has been
shown to have reliable predictive ability, with a sensitivity of 60%
and speciﬁcity of 85% compared with depression diagnoses made
by structured interview (29). The mean SMFQ score for our affected
twins was 12.38, which strongly suggests that these individuals
were experiencing a clinically signiﬁcant level of depressive
symptoms. However, it would be important to replicate these
ﬁndings using a sample of clinically depressed adolescents.
Although our sample contained more female than male twin pairs,
we were not powered to look at sex effects. However, none of the
top-ranked probes showed different levels of DNA methylation
between male and female subjects. One ﬁnal caveat in this study is
that chorionicity data are not available on these twins, a potential
limitation given that whether or not MZ twins share a placenta may
inﬂuence transcriptional and epigenomic differences (47).
In conclusion, we have identiﬁed DNA methylation differences
associated with adolescent depressive symptoms in peripheral
DNA samples from discordant MZ twin pairs. Two of the top-
ranked DMPs were found to be differentially methylated in
postmortem brain tissue samples from individuals with MDD. Such
trait-speciﬁc differentially methylated regions that are stable across
tissues are of particular interest because they have potential use as
biomarkers. Together, these data along with ﬁndings emerging
from other studies of depression provide evidence for a role of
epigenetic variation in the etiology of depression.
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